Literature DB >> 1488490

Bulimia nervosa: a 5-year follow-up study.

E Johnson-Sabine1, D Reiss, D Dayson.   

Abstract

Fifty patients with bulimia nervosa were followed up for a minimum length of 5 years. Standardized interviews, observer-rated instruments and self-rated questionnaires were employed both at entry and at completion of the follow-up period. After tracing, the positive response rate was 72%; one patient had died. At the time of follow-up 31% of those traced had made a complete recovery and 25% still fulfilled diagnostic criteria for bulimia nervosa. Judged on behavioural symptoms 47.2% of responders had a 'good' outcome. Good outcome was associated with fewer social problems, higher social class, and a significant improvement in eating attitudes at follow-up. All outcome groups reported a reduction of interference by symptoms in other areas of life, and an improvement in mood state. No factors, including those described in previous studies, were identified which predicted outcome.

Entities:  

Mesh:

Year:  1992        PMID: 1488490     DOI: 10.1017/s0033291700038526

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  3 in total

1.  Does impulsivity predict outcome in treatment for binge eating disorder? A multimodal investigation.

Authors:  Stephanie M Manasse; Hallie M Espel; Leah M Schumacher; Stephanie G Kerrigan; Fengqing Zhang; Evan M Forman; Adrienne S Juarascio
Journal:  Appetite       Date:  2016-05-24       Impact factor: 3.868

2.  Impulsivity and affect reactivity prospectively predict disordered eating attitudes in adolescents: a 6-year longitudinal study.

Authors:  Brittney C Evans; Julia W Felton; Madeline A Lagacey; Stephanie M Manasse; Carl W Lejuez; Adrienne S Juarascio
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-01-29       Impact factor: 4.785

Review 3.  Does concurrent psychopathology at presentation influence response to treatment for bulimia nervosa?

Authors:  L Bell
Journal:  Eat Weight Disord       Date:  2002-09       Impact factor: 4.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.